| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.009 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.077 | 0.009 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.009 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |